Publikasjoner fra Legemiddelregisteret
Artikkel
|Publisert
Oversikt over forskningsartikler der data fra Legemiddelregisteret er brukt. LMR startet utlevering av data til prosjekt i 2023, og flere av publikasjoner i oversikten har derfor brukt data fra Reseptregistret.
Forskere og andre kan søke om tilgang til statistikk eller data fra Legemiddelregisteret og de andre helseregistrene som Folkehelseinstituttet er dataansvarlig for. Helseregistre er en unik kilde til kunnskap om befolkningens helse, årsaker til sykdom og kvaliteten på helse- og omsorgstjenestene.
Tidsskriftartiklene er enten e-publisert eller endelig publisert i aktuelt år. Publikasjonslisten inneholder også masteroppgaver, doktorgradsoppgaver og rapporter. Listene er basert på metodiske søk i artikkeldatabaser. Listen kan være ufullstendig eller inneholde for mange publikasjoner, avhengig av hvordan kildeopplysningene er angitt i artiklene.
2023
Tidsskriftartikler
Aas E, Burger E, Matveev N, Bjørnelv GMW. Økonomisk evaluering av helsetiltak – en strukturert gjennomgang av studier gjennomført i Norge. Magma. 2023;26(5):143-53.
Anjum M, Ariansen I, Hjellvik V, Selmer R, Kjerpeseth LJ, Skovlund E, Myrstad M, Ellekjær H, Christophersen IE, Tveit A, Berge T. Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study. Eur Heart J. 2024;45(1):57-66.
Arendt Nielsen L, Schepman P, Hygge Blakeman K, Wilhelm S, Robinson R, Beck C, Liseth Hansen J, Rolfson O. Prescription patterns and predictors of unmet pain relief in patients with difficult-to-treat osteoarthritis in the Nordics: analyses from the BISCUITS study. Scand J Pain. 2023;23(1):149-60.
Askim T, Hokstad A, Bergh E, Døhl Ø, Ellekjær H, Ihle-Hansen H, Indredavik B, Leer ASM, Lydersen S, Saltvedt I, Seljeseth Y, Thommessen B. Multimodal individualised intervention to prevent functional decline after stroke: protocol of a randomised controlled trial on long-term follow-up after stroke (LAST-long). BMJ Open. 2023;13(5):e069656.
Berg IJ, Tveter AT, Bakland G, Hakim S, Kristianslund EK, Lillegraven S, Macfarlane GJ, Moholt E, Provan SA, Sexton J, Thomassen EE, De Thurah A, Gossec L, Haavardsholm EA, Østerås N. Follow-Up of Patients With Axial Spondyloarthritis in Specialist Health Care With Remote Monitoring and Self-Monitoring Compared With Regular Face-to-Face Follow-Up Visits (the ReMonit Study): Protocol for a Randomized, Controlled Open-Label Noninferiority Trial. JMIR Res Protoc. 2023;12:e52872.
Bhargava S, Botteri E, Berthelsen M, Iqbal N, Randel KR, Holme Ø, Berstad P. Lower participation among immigrants in colorectal cancer screening in Norway. Front Public Health. 2023;11:1254905.
Bjerre A, Aase SA, Radtke M, Siva C, Gudmundsdottir H, Forsberg B, Woldseth B, Brackman D. The effects of transitioning from immediate release to extended release cysteamine therapy in Norwegian patients with nephropathic cystinosis: a retrospective study. Pediatr Nephrol. 2023;38(11):3671-9.
Bjørge T, Hjellvik V, Bjørge L, Dos-Santos-Silva I, Furu K, Kvåle R, Engeland A. Incidence and prevalence of drugs used for chronic diseases in survivors of adult-onset gynaecological cancer - a nationwide cohort study. BJOG. 2023;130(7):770-8.
Bojanić I, Bjerkeset O, Williams LJ, Berk M, Bjørngaard JH, Sund ER, Sletvold H. Risk of antidepressant initiation among users of cardiovascular agents and metformin. Findings from the Trøndelag Health Study (HUNT) and Norwegian Prescription Database (NorPD), Norway. Pharmacol Res Perspect. 2023;11(2):e01078.
Børø S, Thoresen S, Boge Brant S, Helland Å. Initial investigation of using Norwegian health data for the purpose of external comparator arms - an example for non-small cell lung cancer. Acta Oncol. 2023;62(12):1642-8.
Brikell I, Yao H, Li L, Astrup A, Gao L, Gillies MB, Xie T, Zhang-James Y, Dalsgaard S, Engeland A, Faraone SV, Haavik J, Hartman C, Ip P, Jakobsdóttir Smári U, Larsson H, Man KK, de Oliveira Costa J, Pearson SA, Hostrup Nielsen NP, Snieder H, Wimberley T, Wong IC, Zhang L, Zoega H, Klungsøyr K, Chang Z. ADHD medication discontinuation and persistence across the lifespan: a retrospective observational study using population-based databases. Lancet Psychiatry. 2024;11(1):16-26.
Bröms G, Hernandez-Diaz S, Huybrechts KF, Bateman BT, Kristiansen EB, Einarsdóttir K, Engeland A, Furu K, Gissler M, Karlsson P, Klungsøyr K, Lahesmaa-Korpinen AM, Mogun H, Nørgaard M, Reutfors J, Sørensen HT, Zoega H, Kieler H. Atomoxetine in Early Pregnancy and the Prevalence of Major Congenital Malformations: A Multinational Study. J Clin Psychiatry. 2023;84(1):22m14430.
Cesta CE, Rotem R, Bateman BT, Chodick G, Cohen JM, Furu K, Gissler M, Huybrechts KF, Kjerpeseth LJ, Leinonen MK, Pazzagli L, Zoega H, Seely EW, Patorno E, Hernández-Díaz S. Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy. JAMA Intern Med. 2024;184(2):144-52.
Chang A, Botteri E, Gillis RD, Löfling L, Le CP, Ziegler AI, Chung NC, Rowe MC, Fabb SA, Hartley BJ, Nowell CJ, Kurozumi S, Gandini S, Munzone E, Montagna E, Eikelis N, Phillips SE, Honda C, Masuda K, Katayama A, Oyama T, Cole SW, Lambert GW, Walker AK, Sloan EK. Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer. Sci Transl Med. 2023;15(693):eadf1147.
Chock EY, Dahal S, Grimshaw AA, Suter L, Liew Z, Felson D. Offspring neurodevelopmental outcomes born to parents with chronic inflammatory arthritis using antirheumatic therapies: A scoping review. Semin Arthritis Rheum. 2023;61:152230.
Christensen JJ, Bogsrud MP, Holven KB, Retterstøl K, Veierød MB, Nordeng H. Use of statins and other lipid-modifying agents across pregnancy: A nationwide drug utilization study in Norway in 2005-2018. Atherosclerosis. 2023;368:25-34.
Closs ER, Lyamouri M, Øymar K, Størdal K. Regionale forskjeller i bruk av protonpumpehemmere hos barn. [Regional differences in the use of proton pump inhibitors in children]. Tidsskr Nor Laegeforen. 2023;143(9):782-7.
Closs ER, Mårild K, Nielsen RG, Størdal K. Use of proton pump inhibitors in scandinavian children and adolescents: An observational study. Front Pediatr. 2023;11:1052978.
Cohen JM, Alvestad S, Cesta CE, Bjørk MH, Leinonen MK, Nørgaard M, Einarsdóttir K, Engeland A, Gissler M, Karlstad Ø, Klungsøyr K, Odsbu I, Reutfors J, Selmer RM, Tomson T, Ulrichsen SP, Zoega H, Furu K. Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations. Ann Neurol. 2023;93(3):551-62.
Cohen JM, Alvestad S, Suarez EA, Schaffer A, Selmer RM, Havard A, Bateman BT, Cesta CE, Zoega H, Odsbu I, Huybrechts KF, Kjerpeseth LJ, Straub L, Leinonen MK, Bjørk MH, Nørgaard M, Gissler M, Ulrichsen SP, Hernandez-Diaz S, Tomson T, Furu K. Comparative Risk of Major Congenital Malformations With Antiseizure Medication Combinations vs Valproate Monotherapy in Pregnancy. Neurology 2024;102(2): e207996.
Cohen JM, Srinivas C, Furu K, Cesta CE, Reutfors J, Karlstad Ø. Prevalence trends and individual patterns of ADHD medication use in pregnancy in Norway and Sweden, 2010-2019. Eur J Clin Pharmacol. 2023;79(1):173-80.
de Carvalho JF, Skare T. Low-Dose Naltrexone in Rheumatological Diseases. Mediterr J Rheumatol. 2023;34(1):1-6.
de Oliveira J, Moreira ELG, de Bem AF. Beyond cardiovascular risk: Implications of Familial hypercholesterolemia on cognition and brain function. Ageing Res Rev. 2024;93:102149.
Dong L, Nygård M, Støer NC, Klungsøyr O, Hansen BT. Real-world effectiveness of HPV vaccination against cervical neoplasia among birth cohorts ineligible for routine vaccination. Int J Cancer. 2023;153(2):399-406.
Dreier JW, Bjørk MH, Alvestad S, Gissler M, Igland J, Leinonen MK, Sun Y, Zoega H, Cohen JM, Furu K, Tomson T, Christensen J. Prenatal Exposure to Antiseizure Medication and Incidence of Childhood- and Adolescence-Onset Psychiatric Disorders. JAMA Neurol. 2023;80(6):568-77.
Dudukina E, Szépligeti SK, Karlsson P, Asomaning K, Daltveit AK, Hakkarainen K, Hoti F, Kieler H, Lunde A, Odsbu I, Rantanen M, Reutfors J, Saarelainen L, Ehrenstein V, Toft G. Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countries. Drug Saf. 2023;46(7):661-75.
Eide D, McDonald R, Hamina A, Clausen T, Odsbu I, Skurtveit S. Prescription high-risk polysubstance use among opioid maintenance treatment patients. Int J Drug Policy. 2024:104196.
Eide IJZ, Nilssen Y, Stensland EM, Brustugun OT. Real-World Data on EGFR and ALK Testing and TKI Usage in Norway-A Nation-Wide Population Study. Cancers (Basel). 2023;15(5):1505.
Engström A, Wintzell V, Melbye M, Hviid A, Eliasson B, Gudbjörnsdottir S, Hveem K, Jonasson C, Svanström H, Pasternak B, Ueda P. Sodium-Glucose Cotransporter 2 Inhibitor Treatment and Risk of Atrial Fibrillation: Scandinavian Cohort Study. Diabetes Care. 2023;46(2):351-60.
Engström A, Wintzell V, Melbye M, Svanström H, Eliasson B, Gudbjörnsdottir S, Hveem K, Jonasson C, Hviid A, Ueda P, Pasternak B. Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A scandinavian cohort study. Hepatology. 2024; 79(6):1401-1411.
Eriksen AMA, Melhus M, Schei B, Skurtveit S, Broderstad AR. Opioid prescriptions among Sami and non-Sami with chronic pain: The SAMINOR 2 Questionnaire Survey and the Norwegian Prescription Database. Int J Circumpolar Health. 2023;82(1):2241202.
Ernstsen L, Zotcheva E, Sui X, Engstrøm M, Martínez-Velilla N, Bjerkeset O, Bjorvatn B, Havnen A. Association Between Cardiorespiratory Fitness and Incident Purchase of Hypnotic Drugs in Adults: The HUNT Study. Mayo Clin Proc. 2023;98(2):229-38.
Espnes KA, Nøst TH, Handal M, Skurtveit SO, Langaas HC. Can academic detailing reduce opioid prescriptions in chronic non-cancer pain? BMC Prim Care. 2023;24(1):84.
Gehrt L, Laake I, Englund H, Nieminen H, Feiring B, Lahdenkari M, Palmu AA, Trogstad L, Benn CS, Sørup S. Cohort Profile: Childhood morbidity and potential non-specific effects of the childhood vaccination programmes in the Nordic countries (NONSEnse): register-based cohort of children born 1990-2017/2018. BMJ Open. 2023;13(2):e065984.
Ghiasvand R, Berge LAM, Andreassen BK, Green AC, Al Rahmoun M, Fournier A, Kvaskoff M, Veierød MB, Robsahm TE. Statin use and risk of cutaneous melanoma: a nationwide nested case-control study. Research letter. Br J Dermatol. 2023;188(6):805-7.
Ghiasvand R, Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Karlstad Ø, Juzeniene A, Larsen IK, Green AC, Veierød MB, Robsahm TE. Use of antihypertensive drugs and risk of cutaneous melanoma: a nationwide nested case-control study. Int J Epidemiol. 2023;52(3):887-98.
Gjerde LC, Skurtveit S, Handal M, Nesvåg R, Clausen T, Lid TG, Hamina A, Borchgrevink PC, Odsbu I. Mental disorder prevalence in chronic pain patients using opioid versus non-opioid analgesics: A registry-linkage study. Eur J Pain. 2023;27(7):884-95.
Hamina A, Odsbu I, Hjellvik V, Lid TG, Clausen T, Skurtveit S. Fatal drug overdoses in individuals treated pharmacologically for chronic pain: a nationwide register-based study. Br J Anaesth. 2024;132(1):86-95.
Hansen KL, Fluke J, Gesink D, Friborg O, Sørlie T, Merkel-Holguin L, Martinussen M. Study Protocol: The Arctic Childhood Study: a Study of Violence and Health in Indigenous Sámi and Non-Sámi Children and Youth in Arctic Norway—a Mixed Methods Cohort Study Design. International journal on child maltreatment : research, policy and practice. 2023;6(2):165-203.
Hansen S, von Bülow A, Sandin P, Ernstsson O, Janson C, Lehtimäki L, Kankaanranta H, Ulrik C, Aarli BB, Fues Wahl H, Geale K, Tang ST, Wolf M, Larsen T, Altraja A, Backman H, Kilpeläinen M, Viinanen A, Ludviksdottir D, Kauppi P, Sverrild A, Lehmann S, Backer V, Yasinska V, Skjold T, Karjalainen J, Bossios A, Porsbjerg C. Prevalence and management of severe asthma in the Nordic countries: findings from the NORDSTAR cohort. ERJ Open Res. 2023;9(2):00687-2022.
Hartman CA, Larsson H, Vos M, Bellato A, Libutzki B, Solberg BS, Chen Q, Du Rietz E, Mostert JC, Kittel-Schneider S, Cormand B, Ribasés M, Klungsøyr K, Haavik J, Dalsgaard S, Cortese S, Faraone SV, Reif A. Anxiety, mood, and substance use disorders in adult men and women with and without attention-deficit/hyperactivity disorder: A substantive and methodological overview. Neurosci Biobehav Rev. 2023;151:105209.
Hartman EAR, van de Pol AC, Heltveit-Olsen SR, Lindbæk M, Høye S, Lithén SS, Sundvall PD, Sundvall S, Arnljots ES, Gunnarsson R, Kowalczyk A, Godycki-Cwirko M, Platteel TN, Groen WG, Monnier AA, Zuithoff NP, Verheij TJM, Hertogh C. Effect of a multifaceted antibiotic stewardship intervention to improve antibiotic prescribing for suspected urinary tract infections in frail older adults (ImpresU): pragmatic cluster randomised controlled trial in four European countries. BMJ. 2023;380:e072319.
Havnen A, Zotcheva E, Bjerkeset O, Sui X, Ernstsen L. Cardiorespiratory fitness and incident use of anxiolytics and antidepressants in adults. A linkage study between HUNT and the Norwegian Prescription Database. J Affect Disord. 2023;339:111-7.
Havnes K, Svendsen K, Johansen JS, Granas AG, Garcia BH, Halvorsen KH. Is anticholinergic and sedative drug burden associated with postdischarge institutionalization in community-dwelling older patients acutely admitted to hospital? A Norwegian registry-based study. Pharmacoepidemiol Drug Saf. 2023;32(6):607-16.
Heggland T, Vatten LJ, Opdahl S, Weedon-Fekjær H. Non-progressive breast carcinomas detected at mammography screening: a population study. Breast Cancer Res. 2023;25(1):80.
Helland Å, Myklebust T, Conte S, Frederiksen LE, Aarøe J, Enerly E. EGFR-mutation testing, treatment patterns and clinical outcomes in patients with stage IB-IIIA non-small cell lung cancer in Norway-a nationwide cohort study. Cancer Treat Res Commun. 2023;38:100785.
Hermann M, Holt MD, Kjome RLS, Teigen A. Medication reconciliation-is it possible to speed up without compromising quality? A before-after study in the emergency department. Eur J Hosp Pharm. 2023;30(6):310-5.
Hestetun S, Andersen S, Sanner H, Størdal K. Antibiotic exposure in prenatal and early life and risk of juvenile idiopathic arthritis: a nationwide register-based cohort study. RMD Open. 2023;9(3):e003333.
Hetlevik Ø, Smith-Sivertsen T, Haukenes I, Ruths S, Baste V. Young adults with depression: A registry-based longitudinal study of work-life marginalisation. The Norwegian GP-DEP study. Scand J Public Health. 2024; 52(5):590-597.
Hofstad T, Nyttingnes O, Markussen S, Johnsen E, Killackey E, McDaid D, Rinaldi M, Dean K, Brinchmann B, Douglas K, Gröning L, Bjørkly S, Palmstierna T, Strømme MF, Blindheim A, Rugkåsa J, Hofmann BM, Pedersen R, Widding-Havneraas T, Rypdal K, Mykletun A. Long term outcomes and causal modelling of compulsory inpatient and outpatient mental health care using Norwegian registry data: Protocol for a controversies in psychiatry research project. Int J Methods Psychiatr Res. 2023;33(1):e1980.
Højlund M, Gudmundsson LS, Andersen JH, Saastamoinen LK, Zoega H, Skurtveit SO, Wastesson JW, Hallas J, Pottegård A. Use of benzodiazepines and benzodiazepine-related drugs in the Nordic countries between 2000 and 2020. Basic Clin Pharmacol Toxicol. 2023;132(1):60-70.
Holmberg ST, Skurtveit S, Gulati S, Salvesen Ø O, Nygaard Ø P, Solberg TK, Fredheim OMS. Persistent Use of Prescription Opioids Before and After Lumbar Spine Surgery: Observational Study With Prospectively Collected Data From Two Norwegian National Registries. Spine (Phila Pa 1976). 2023;48(14):969-77.
Hrozanova M, Meisingset I, Kallestad H, Pallesen S, Nordstoga AL, Skarpsno ES. Group-delivered cognitive behavioural therapy versus waiting list in the treatment of insomnia in primary care: study protocol for a pragmatic, multicentre randomized controlled trial. BMC Prim Care. 2023;24(1):61.
Huybrechts KF, Straub L, Karlsson P, Pazzagli L, Furu K, Gissler M, Hernandez-Diaz S, Nørgaard M, Zoega H, Bateman BT, Cesta CE, Cohen JM, Leinonen MK, Reutfors J, Selmer RM, Suarez EA, Ulrichsen SP, Kieler H. Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US. JAMA Psychiatry. 2023;80(2):156-66.
Ikdahl E, Rollefstad S, Kazemi A, Provan SA, Larsen TL, Semb AG. Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism in patients with inflammatory joint disease-results from the nationwide Norwegian Cardio-rheuma registry. Eur Heart J Cardiovasc Pharmacother. 2024;10(1):27-34.
Johansson ALV, Skog A, Johannesen TB, Myklebust T, Skovlund CW, Mørch LS, Friis S, Gamborg M, Kristiansen MF, Pettersson D, Ólafsdóttir EJ, Birgisson H, Palsson R, Eythorsson E, Irenaeus S, Lambe M, Ursin G. Were cancer patients worse off than the general population during the COVID-19 pandemic? A population-based study from Norway, Denmark and Iceland during the pre-vaccination era. Lancet Reg Health Eur. 2023;31:100680.
Jørgensen OJ, Steineger JE, Hillarp A, Pareli Wåland E, Holme PA, Heimdal K, Dheyauldeen S. Elevated FVIII levels in hereditary hemorrhagic telangiectasia: Implications for clinical management. Laryngoscope Investig Otolaryngol. 2024;9(1):e1196.
Karlsen HR, Løchen ML, Langvik E. Antidepressant use and risk of myocardial infarction A long:itudinal investigation of sex-specific associations in the HUNT study. Psychosom Med. 2023;85(1):26-33.
Kerola AM, Rollefstad S, Kazemi A, Wibetoe G, Sexton J, Mars N, Kauppi M, Kvien TK, Haavardsholm EA, Semb AG. Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents. Scand J Rheumatol. 2023;52(1):42-50.
Keskin-Arslan E, Erol H, Uysal N, Karadas B, Temiz T, Kaplan YC. Pregnancy outcomes following maternal macrolide use: A systematic review and meta-analysis. Reprod Toxicol. 2023;115:124-46.
Kinge JM, Dieleman JL, Karlstad Ø, Knudsen AK, Klitkou ST, Hay SI, Vos T, Murray CJL, Vollset SE. Disease-specific health spending by age, sex, and type of care in Norway: a national health registry study. BMC Med. 2023;21(1):201.
Kirkøen B, Berstad P, Hoff G, Bernklev T, Randel KR, Holme Ø, de Lange T, Robb KA, Botteri E. Type and Severity of Mental Illness and Participation in Colorectal Cancer Screening. Am J Prev Med. 2023;64(1):76-85.
Kjeldgaard HK, Holvik K, Abrahamsen B, Tell GS, Meyer HE, O'Flaherty M. Explaining declining hip fracture rates in Norway: a population-based modelling study. Lancet Reg Health Eur. 2023;30:100643.
Kjerpeseth LJ, Cesta CE, Furu K, Engeland A, Gissler M, Gulseth HL, Karlstad Ø, Leinonen MK, Pazzagli L, Zoega H, Cohen JM. Metformin Versus Insulin and Risk of Major Congenital Malformations in Pregnancies With Type 2 Diabetes: A Nordic Register-Based Cohort Study. Diabetes Care. 2023;46(8):1556-64.
Kleppang AL, Vettore MV, Hartz I, Haugland SH, Stea TH. Patterns of unhealthy behaviours during adolescence and subsequent anxiety and depression in adulthood: a prospective register linkage study of the HUNT survey and health registries. Int J Behav Nutr Phys Act. 2023;20(1):6.
Kvarstein G, Kindlundh-Högberg AM, Ould Setti M, Namane R, Muzwidzwa R, Richter H, Hakkarainen KM. An observational post-authorization safety study (PASS) of naloxegol drug utilization in four European countries. Pharmacoepidemiol Drug Saf. 2024;33(1):e5710.
Langaas HC, Salvesen Ø, Dyrkorn R, Blix HS, Spigset O. Academic detailing as a method to improve general practitioners' drug prescribing in type 2 diabetes: evaluation of changes in prescribing. Scand J Prim Health Care. 2023;41(3):224-31.
Lien L, Bonsaksen T, Holte Stea T, Kleppang AL, Steigen AM, Leonhardt M. Time trends in self-reported depressive symptoms, prescription of antidepressants, sedatives and hypnotics and the emergence of social media among Norwegian adolescents. PLoS One. 2023;18(12):e0295384.
Løfling L, Støer NC, Nafisi S, Ursin G, Hofvind S, Botteri E. Low-dose aspirin and risk of breast cancer: a Norwegian population-based cohort study of one million women. Eur J Epidemiol. 2023;38(4):413-26.
Løfling LL, Støer NC, Andreassen BK, Ursin G, Botteri E. Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study. Breast Cancer Res. 2023;25(1):101.
Løyland HI, Kine P, Sten Gahmberg S, Gaarder Harsheim I, Sæther EM, Iversen T, Snilsberg Ø, Abelsen B. Effekter, gevinster og kostnader ved digital hjemmeoppfølging–en samfunnsøkonomisk analyse basert på et pragmatisk randomisert forsøk. Magma forskning og viten. 2023;26(5):124-35.
Lund IO, Andersen N, Ask H, Andreas JB. Parental drinking, mental health and educational level, and offspring's subsequent prescription drugs treatment for sleep problems. A longitudinal HUNT survey and registry study. BMC Public Health. 2023;23(1):1372.
Malme KB, Ulstein K, Finbråten AK, Wüsthoff LEC, Kielland KB, Hauge J, Dalgard O, Midgard H. Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study. Int J Drug Policy. 2023;116:104044.
Martinho I, Teixeira Rodrigues A, Guerreiro J, Rocha J, Sepodes B, Torre C. A cross-country utilization patterns comparison of high expenditure therapeutic groups between Portugal and six European countries: the two sides of the Portuguese coin. Expert Rev Pharmacoecon Outcomes Res. 2023;23(1):89-97.
Moen MH, Johansen N. Testosteronbehandling til kvinner. [English version not available] Tidsskr Nor Laegeforen. 2023;143(4):352.
Mohn CH, Blix HS, Brænd AM, Nafstad P, Halvorsen JA. Prevalence of Isotretinoin Therapy in Adolescents and Young Adults With and Without Atopic Dermatitis: A Nationwide Prescription-based Population Study. Acta dermato-venereologica. 2023;103:adv9424.
Næss Ø, Krokstad S, Grimsgaard S, Larsen IK, Meyer HE, Nystad W. Overvåkning av ikke-smittsomme sykdommer. [Norwegian only]. Tidsskr Nor Laegeforen. 2023;143(15):1307-09.
Nafisi S, Randel KR, Støer NC, Veierød MB, Hoff G, Holme Ø, Schult AL, Botteri E. Association between use of low-dose aspirin and detection of colorectal polyps and cancer in a screening setting. Dig Liver Dis. 2023;55(8):1126-32.
Navaratnam M, Vie G, Brevik T, Austad B, Innerdal C, Getz LO, Skjellegrind HK. Prescription of potentially addictive medications after a multilevel community intervention in general practice. Scand J Prim Health Care. 2023;41(1):61-8.
Nestvold HH, Skurtveit SS, Hamina A, Hjellvik V, Odsbu I. Socioeconomic risk factors for long-term opioid use: A national registry-linkage study. Eur J Pain. 2024;28(1):95-104.
Ngo E, Truong MB, Nordeng H. Impact of a primary care pharmacist consultations on pregnant women's medication use: the SafeStart intervention study linked to a national prescription database. Int J Clin Pharm. 2023;45(4):893-902.
Norhammar A, Bodegard J, Vanderheyden M, Tangri N, Karasik A, Maggioni AP, Sveen KA, Taveira-Gomes T, Botana M, Hunziker L, Thuresson M, Banerjee A, Sundström J, Bollmann A. Prevalence, outcomes and costs of a contemporary, multinational population with heart failure. Heart. 2023;109(7):548-56.
Nygård S, Nygård M, Orumaa M, Hansen BT. Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals. Vaccine. 2023;41(37):5469-76.
Nystad W, Hjellvik V, Larsen IK, Robsahm TE, Sund ER, Krokstad S, Hopstock LA, Grimsgaard S, Langhammer A, Bramness JG, Wisløff T, Lergenmuller S, Dalene KE, Meyer HE, Holvik K, Helgeland J, Karlstad Ø, Ariansen I. National health registries - a 'goldmine' for studying non-communicable disease occurrence in Norway - the NCDNOR project. Scand J Public Health. 2024:14034948231214580.
Odsbu I, Handal M, Hjellvik V, Hernandez-Diaz S, Kieler H, Nørgaard M, Skurtveit S, Esen B, Mahic M. Prenatal opioid exposure and risk of asthma in childhood: a population-based study from Denmark, Norway, and Sweden. Front Pharmacol. 2023;14:1056192.
Olstad EW, Nordeng HME, Sandve GK, Lyle R, Gervin K. Effects of prenatal exposure to (es)citalopram and maternal depression during pregnancy on DNA methylation and child neurodevelopment. Transl Psychiatry. 2023;13(1):149.
Pasman JA, Meijsen JJ, Haram M, Kowalec K, Harder A, Xiong Y, Nguyen TD, Jangmo A, Shorter JR, Bergstedt J, Das U, Zetterberg R, Tate A, Lichtenstein P, Larsson H, Odsbu I, Werge T, Reichborn-Kjennerud T, Andreassen OA, Sullivan PF, Buil A, Tesli M, Lu Y. Epidemiological overview of major depressive disorder in Scandinavia using nationwide registers. Lancet Reg Health Eur. 2023;29:100621.
Pettersson AK, Santoni G, Yan J, Radkiewicz C, Xie S, Birgisson H, Ness-Jensen E, von Euler-Chelpin M, Kauppila JH, Lagergren J. Cohort profile: Nordic Helicobacter Pylori eradication project (NordHePEP). Scand J Gastroenterol. 2023;58(5):453-9.
Reilev M, Jensen PB, Ranch LS, Egeberg A, Furu K, Gembert K, Hagg D, Haug U, Karlstad Ø, Reutfors J, Schäfer W, Schwartz S, Smits E, Holthius E, Herings R, Trifirò G, Kirchmayer U, Rosa AC, Belleudi V, Gini R, Støvring H, Hallas J. Methodology of the brodalumab assessment of hazards: a multicentre observational safety (BRAHMS) study. BMJ Open. 2023;13(2):e066057.
Riska BSL, Gunnes N, Stigum H, Finnes TE, Meyer HE, Omsland TK, Holvik K. Time-varying exposure to anti-osteoporosis drugs and risk of first-time hip fracture: a population wide study within the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS). Osteoporos Int. 2023;34(8):1369-79.
Rolová G, Eide D, Gabrhelík R, Odsbu I, Clausen T, Skurtveit S. Gender differences in physical morbidity in opioid agonist treatment patients: population-based cohort studies from the Czech Republic and Norway. Subst Abuse Treat Prev Policy. 2023;18(1):47.
Romanowska J, Bjornevik K, Cortese M, Tuominen JA, Solheim M, Abolpour Mofrad A, Igland J, Scherzer CR, Riise T. Association Between Use of Any of the Drugs Prescribed in Norway and the Subsequent Risk of Parkinson Disease: A Drug-wide Association Study. Neurology. 2023;101(21):e2068-e77.
Rydland E, Høye S, Størdal K. Antibiotic use for airway infections in Norwegian children-A national register-based study. Acta Paediatr. 2024;113(3):537-43.
Sanjinez C, Botteri E, Støer NC, Lukas Löfling L. Antimuscarinics and lung cancer survival: A Norwegian population-based cohort study. Lung Cancer. 2023;179:107187.
Shakibfar S, Zhao J, Li H, Nordeng H, Lupattelli A, Pavlovic M, Sandve GK, Nyberg F, Wettermark B, Hajiebrahimi M, Andersen M, Sessa M. Machine learning-driven development of a disease risk score for COVID-19 hospitalization and mortality: a Swedish and Norwegian register-based study. Front Public Health. 2023;11:1258840.
Sharikabad MN, Skurtveit S, Sommerschild HT, Olsen K, Hartz I, Wesselhoeft R, Hjellvik V, Hauge LJ, Handal M. Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based Study. J Clin Med. 2024;13(4):1075.
Skow M, Fossum GH, Høye S, Straand J, Brænd AM, Emilsson L. Hospitalizations and severe complications following acute sinusitis in general practice: a registry-based cohort study. J Antimicrob Chemother. 2023;78(9):2217-27.
Skow M, Fossum GH, Høye S, Straand J, Emilsson L, Brænd AM. Antibiotic treatment of respiratory tract infections in adults in Norwegian general practice. JAC Antimicrob Resist. 2023;5(1):dlac135.
Skurtveit S, Nestvold HH, Odsbu I. Flere bruker opioider over lang tid: Nytt forskningsfunn. Glimt (medlemsblad for Foreningen for kroniske smertepasienter). 2023(1):10-1.
Slettedal JK, Traustadóttir VD, Sandvik L, Ringvold A. Relationship between the Prevalence of Glaucoma (Estimated Through Prescribed Antiglaucomatous Medication) and Access to Ophthalmologists in Norway. The open ophthalmology journal. 2023;16(1):e187436412212260.
Solberg SM. Psoriasis in Norway: A Prescription-based Registry Study of Incidence and Prevalence. Acta Derm Venereol. 2023;103:adv4591.
Sørensen AMS, Wesselhöeft R, Andersen JH, Reutfors J, Cesta CE, Furu K, Hartz I, Rasmussen L. Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010-2020. Eur Child Adolesc Psychiatry. 2023;32(10):2049-56.
Srinivas C, Karlstad Ø, Stigum H, Furu K, Cesta CE, Reutfors J, Cohen JM. Trajectories of ADHD medication use before, during, and after pregnancy: A population-based study from Norway and Sweden. Pharmacoepidemiol Drug Saf. 2023;32(10):1152-60.
Steen Carlsson K, Winding B, Astermark J, Baghaei F, Brodin E, Funding E, Holmström M, Österholm K, Bergenstråle S, Lethagen S. High use of pain, depression, and anxiety drugs in hemophilia: more than 3000 people with hemophilia in an 11-year Nordic registry study. Res Pract Thromb Haemost. 2023;7(2):100061.
Storås AH, Tsuruda K, Fosså SD, Andreassen BK. Time trends in systemic treatment for patients with metastatic prostate cancer: a national cohort study. Acta Oncol. 2023;62(12):1716-22.
Strandberg RB, Nilsen RM, Pouwer F, Igland J, Forster RB, Jenum AK, Buhl ES, Iversen MM. Lower education and immigrant background are associated with lower participation in a diabetes education program - Insights from adult patients in the Outcomes & Multi-morbidity In Type 2 diabetes cohort (OMIT). Patient Educ Couns. 2023;107:107577.
Svendsen K, Nes LS, Meland A, Larsson IM, Gjelsvik YM, Børøsund E, Rygg CM, Myklebust T, Reinertsen KV, Kiserud CE, Skjerven H, Antoni MH, Chalder T, Mjaaland I, Carlson LE, Eriksen HR, Ursin G. Coping After Breast Cancer: Protocol for a Randomized Controlled Trial of Stress Management eHealth Interventions. JMIR Res Protoc. 2023;12:e47195.
Tiger M, Wesselhoeft R, Karlsson P, Handal M, Bliddal M, Cesta CE, Skurtveit S, Reutfors J. Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic in Scandinavia. J Affect Disord. 2023;323:292-8.
Tousi F, Al Haroni M, Lie SA, Lund B. Antibiotic prescriptions among dentists across Norway and the impact of COVID-19 pandemic. BMC Oral Health. 2023;23(1):649.
Trinh NTH, Munk-Olsen T, Wray NR, Bergink V, Nordeng HME, Lupattelli A, Liu X. Timing of Antidepressant Discontinuation During Pregnancy and Postpartum Psychiatric Outcomes in Denmark and Norway. JAMA Psychiatry. 2023;80(5):441-50.
Tuominen JA, Bjørnevik K, Romanowska J, Solheim MH, Grydeland TB, Cortese M, Scherzer CR, Riise T, Igland J. Beta2-adrenoreceptor agonists and long-term risk of Parkinson's disease. Parkinsonism Relat Disord. 2023;110:105389.
Ueda P, Wintzell V, Melbye M, Eliasson B, Söderling J, Gudbjörnsdottir S, Hveem K, Jonasson C, Svanström H, Hviid A, Pasternak B. Use of DPP4 Inhibitors and GLP-1 Receptor Agonists and Risk of Intestinal Obstruction: Scandinavian Cohort Study. Clin Gastroenterol Hepatol. 2024;22(6):1226-1237.e14.
Ukah UV, Platt RW, Nordeng HME. Impact of COVID-19 Pandemic on Dispensing of Cardiovascular Drugs in Norway: An Interrupted Time Series Study. Am J Prev Med. 2024;66(4):672-80.
Vinter N, Halminen O, Lehto M, Airaksinen KEJ, Andersson T, Wändell P, Holzmann M, Rutherford OC, Halvorsen S, Cordsen P, Frost L, Johnsen SP. Geographical variation in persistence to oral anticoagulation therapy and clinical outcomes among patients with atrial fibrillation initiating therapy in Denmark, Sweden, Norway and Finland. Basic Clin Pharmacol Toxicol. 2023;133(2):168-78.
Widding-Havneraas T, Elwert F, Markussen S, Zachrisson HD, Lyhmann I, Chaulagain A, Bjelland I, Halmøy A, Rypdal K, Mykletun A. Effect of ADHD medication on risk of injuries: a preference-based instrumental variable analysis. Eur Child Adolesc Psychiatry. 2024;33(6):1987-1996.
Widding-Havneraas T, Zachrisson HD, Markussen S, Elwert F, Lyhmann I, Chaulagain A, Bjelland I, Halmøy A, Rypdal K, Mykletun A. Effect of Pharmacological Treatment of Attention-Deficit/Hyperactivity Disorder on Criminality. J Am Acad Child Adolesc Psychiatry. 2024;63(4):433-42.
Ødegaard KM, Lirhus SS, Melberg HO, Hallén J, Halvorsen S. Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014-2020. ESC Heart Fail. 2023;10(1):405-15.
Rapporter og annet
Abel MH, Dahl L, Brantsæter AL, Åsvold BO. Overvåkning av jodstatus og jodrelaterte stoffskiftesykdommer i Norge – en kartlegging av behov og muligheter og anbefalinger for veien videre. [Monitoring iodine status and iodine related thyroid diseases in Norway – mapping needs and opportunities, and recommendations for strategy]. Notat. Folkehelseinstituttet. Senter for bærekraftig kosthold, Oslo, 2023.
Bakken GV, Henjum K, Skoufa II, Granum T, Sharikabad MN, Dansie LS. Legemiddelforbruket i Norge 2018-2022 - Data fra Grossistbasert legemiddelstatistikk. Rapport. ISBN: 978-82-8406-402-4. Folkehelseinstituttet. Område for helsedata og digitalisering, 2023.
Bratland-Sanda S, Krane V, Trangsrud LKJ, Schmidt SK. Liv og røre i videregående opplæring. Sluttrapport fra pilotprosjekt med Kragerø videregående skole. Rapport. Skriftserien Nr. 111. ISSN: 2535-5325, ISBN: 978-82-7206-743-3. Universitetet i Sørøst-Norge, 2023.
Kløvstad H, Blindheim MI, Skullerud KH, Dalgard O, Midgard H, Wüsthoff LEC, Kielland KB, Hauge J, Whittaker R. Statusrapport om eliminasjon av hepatitt B og C som folkehelseproblem i Norge. Oppfølging av den nasjonale strategien mot virale hepatitter. [Status report on the elimination of hepatitis B and C as a public health threat in Norway]. Folkehelseinstituttet, Oslo, 2023.
Kran A-MB, Håvelsrud OE, Storm ML, Blix HS, Bragstad K, Stene-Johansen K, Rohringer A, Tylden GD, Birkeland Kro G, Rykkvin R, Ormaasen V, Marvik Å, Njølstad G, Nilsen H-JS, Reikvam DH. Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2022. RAVN. Report. [Forekomst av antiviral resistens i Norge 2022]. Norwegian Institute of Public Health. [Folkehelseinstituttet]. Oslo, 2023.
Stoltenberg C, et al. Folkehelseinstituttet - Årsrapport 2022. Våre folk, vår kunnskap og våre tjenester er sterkt etterspurt, selv om finansieringen er vanskeligere. Folkehelseinstituttet, Oslo, 2023.
Avhandlinger - PhD, Master og Bachelor
Bayram K. Hvor stor andel av diabetespasienter i Tromsø7 når behandlingsmålet for HbA1c? Thesis [Master]. Tromsø: UiT - Norges arktiske universitet; 2023.
Bojanić I. Depression and anxiety in cardiovascular diseases and diabetes: Prevalence trends and drug treatments 1995-2019 A linkage between the Trøndelag Health Study (HUNT) and the Norwegian Prescription Database (NorPD). Thesis [PhD]. Trondheim: NTNU; 2023.
Cioni L. Human Exposure to PFAS and Other Anthropogenic Organofluorine Chemicals in Tromsø between 1986 and 2015. Thesis [PhD]. Tromsø: UiT - The Arctic University; 2023.
Hanøy E. Alkohol og legemidlar blant eldre: eit aukande helseproblem? Thesis [Bachelor]: Høgskulen på Vestlandet; 2023.
Havdal LB. Appropriate level of care for children with viral lower respiratory tract infection. Thesis [PhD]. Oslo: University of Oslo; 2023.
Hopland E. Legemiddelgjennomgang ved omsorgsskifter. Hvilke endringer skjer i legemiddellisten, og i hvor stor grad er bruken av antikolinerge legemidler til eldre? Thesis [Master]. Oslo: Universitetet i Oslo; 2023.
Kluge KE, Aursnes A, Jazdauskaite A, Raymond G, Anwar M, Halling H, Tran ML. SGLT2-hemmere for kronisk nyresvikt ved nyremedisinsk avdeling på OUS. (Prosjektbeskrivelse). Thesis [Master]. Oslo: Universitetet i Oslo; 2023.
Nag MH. Hvilke erfaringer gir PALS-modellen for elever med ADHD? En kvalitativ undersøkelse av PALS-modellen gjennom lærere og PALS-veiledere. Thesis [Master]. Bergen: The University of Bergen; 2023.
Ngo ETP. Novel interventions for pregnant women: Pharmacist consultations and mobile applications in pregnancy – with focus on the management of nausea and vomiting during pregnancy. Thesis [PhD]. Oslo: University of Oslo; 2023.
Nygård PØ. Endring i bruk av ADHD-medikamenter i Norge og Sverige fra 2006-2020. Thesis [Bachelor]. Trondheim: NTNU; 2023.
Olsen Andreassen A, Strandmo M. ADHD på ungdomsskolen - hvordan gjør vi det? Thesis [Master]. Tromsø: UiT Norges arktiske universitet; 2023.
Olstad EW. Prenatal medication exposure, DNA methylation and child neurodevelopment. Thesis [PhD]. Oslo: University of Oslo; 2023.
Sande AK. Early-onset preeclampsia in the balance of Immunology and Pregnancy: Risk factors, the Role of Allergy, and potential protection by Antihistamine use. Thesis [PhD]. Bergen: The University of Bergen, Faculty of Medicine; 2023.
Strandmo M, Andreassen AO. ADHD på ungdomsskolen - hvordan gjør vi det? Thesis [Master]. Tromsø: UiT Norges arktiske universitet; 2023.
Sundbakk LM. Benzodiazepines and z-hypnotics in pregnancy and child neurodevelopment: with focus on causal inference methods in perinatal pharmacoepidemiology. Thesis. Oslo: University of Oslo; 2023.
Søbakk OM. Bruk av direktevirkende orale antikoagulantia hos eldre multidosepasienter - en studie av interaksjoner, fallrelaterte legemidler og antikolinerge legemidler. Thesis [Master]. Oslo: Universitetet i Oslo; 2023.
Tallaksen EMØ. Bruk av antidepressiva i Norge - utvikling og forskjeller i alder og kjønn [Bachelor]. Trondheim: NTNU; 2023.
Welch SAS. Predicting environmental risks from pharmaceuticals under future scenarios: a Norwegian example. Thesis [PhD]. Oslo: University of Oslo, ; 2023.
Widding-Havnerås T. Effect of ADHD Medication on Criminality and Injuries: Quasi-Experimental Evidence for Patients on the Margin of Treatment. Thesis [PhD]. Bergen: The University of Bergen; 2023.
Ødegaard KM. Heart failure in Norway : incidence, prevalence, and compliance to pharmacotherapy: insights from Norwegian nationwide health registries. Thesis [PhD]. Oslo: University of Oslo; 2023.